Table 1 Clinical characteristics of participants with and without hyperthyroidism

Sex, male, n (%)

18 (18.0)

20 (22.7)

0.421

Age, years

40.89 ± 10.99

40.28 ± 12.96

0.729

BMI, kg/m²

24.23 ± 4.11

21.94 ± 3.43

 < 0.001

TC, mmol/L

5.13 ± 0.94

3.52 ± 0.58

 < 0.001

HDL-C, mmol/L

1.38 ± 0.37

1.14 ± 0.25

 < 0.001

LDL-C, mmol/L

3.26 ± 0.99

1.94 ± 0.60

 < 0.001

TG, mmol/L

1.14 (0.81, 1.93)

1.13 (0.83, 1.50)

0.239

FBG, mmol/L

5.04 (4.73, 5.34)

5.11 (4.72, 5.61)

0.308

FINS, uIU/mL

9.3 (6.5, 13.4)

10.9 (7.4, 15.9)

0.139

HOMA-IR

2.24 (1.39, 3.38)

2.59 (1.64, 3.50)

0.182

eGFR, mL/min/1.73 m²

111.3 ± 12.88

129.3 ± 17.06

 < 0.001

FT3, pg/mL

3.28 (3.03, 3.47)

14.57 (8.92, 20.00)

 < 0.001

FT4, ng/dL

1.26 (1.15, 1.38)

4.50 (2.90, 6.31)

 < 0.001

TSH, μIU/mL

1.88 (1.35, 2.50)

0.01 (0.01, 0.01)

 < 0.001

Metrnl, pg/mL

190.3 (165.4, 214.4)

227.2 (192.3, 289.2)

 < 0.001